Schrödinger Q3 2023 Investor Presentation Update

Schrödinger presents Q3 FY23 financial and operational updates as a provider of science-based software and consulting solutions for pharmaceutical drug development. The company focuses on accelerating development timelines, reducing R&D costs, and improving patient outcomes through innovative platform solutions.